Your browser doesn't support javascript.
loading
Indications and utility of cardiac genetic testing in athletes.
Castelletti, Silvia; Gray, Belinda; Basso, Cristina; Behr, Elijah R; Crotti, Lia; Elliott, Perry M; Gonzalez Corcia, Cecilia M; D'Ascenzi, Flavio; Ingles, Jodie; Loeys, Bart; Pantazis, Antonis; Pieles, Guido E; Saenen, Johan; Sarquella Brugada, Georgia; Sanz de la Garza, Maria; Sharma, Sanjay; Van Craenebroek, Emeline M; Wilde, Arthur; Papadakis, Michael.
Affiliation
  • Castelletti S; IRCCS Istituto Auxologico Italiano, Cardiology Department, Milan, Italy.
  • Gray B; Cardiovascular Clinical Academic Group and Cardiology Research Centre, Institute of Molecular and Clinical Sciences, St George's, University of London and St George's University Hospitals NHS Foundation Trust, London, UK.
  • Basso C; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Behr ER; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Crotti L; Cardiovascular Pathology Unit, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
  • Elliott PM; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart, Amsterdam, The Netherlands.
  • Gonzalez Corcia CM; Cardiovascular Clinical Academic Group and Cardiology Research Centre, Institute of Molecular and Clinical Sciences, St George's, University of London and St George's University Hospitals NHS Foundation Trust, London, UK.
  • D'Ascenzi F; IRCCS Istituto Auxologico Italiano, Cardiology Department, Milan, Italy.
  • Ingles J; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart, Amsterdam, The Netherlands.
  • Loeys B; Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.
  • Pantazis A; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
  • Pieles GE; Department of Sports Cardiology and Screening, Aspetar Sports Medicine Hospital, Doha, Qatar.
  • Saenen J; Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Sarquella Brugada G; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Sanz de la Garza M; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
  • Sharma S; Centenary Institute, The University of Sydney, Sydney, Australia.
  • Van Craenebroek EM; Centre for Population Genomics, Garvan Institute of Medical Research, and UNSW Sydney, Sydney, Australia.
  • Wilde A; Department of Clinical Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Papadakis M; Center for Medical Genetics, Antwerp University Hospital & University of Antwerp, Antwerp, Belgium.
Eur J Prev Cardiol ; 29(12): 1582-1591, 2022 09 07.
Article in En | MEDLINE | ID: mdl-36070487
ABSTRACT
Sports Cardiology practice commonly involves the evaluation of athletes for genetically determined cardiac conditions that may predispose to malignant arrhythmias, heart failure, and sudden cardiac death. High-level exercise can lead to electrical and structural cardiac remodelling which mimics inherited cardiac conditions (ICCs). Differentiation between 'athlete's heart' and pathology can be challenging and often requires the whole armamentarium of available investigations. Genetic studies over the last 30 years have identified many of the genetic variants that underpin ICCs and technological advances have transformed genetic testing to a more readily available and affordable clinical tool which may aid diagnosis, management, and prognosis. The role of genetic testing in the evaluation and management of athletes with suspected cardiac conditions is often unclear beyond the context of specialist cardio-genetics centres. This document is aimed at physicians, nurses, and allied health professionals involved in the athlete's care. With the expanding role and availability of genetic testing in mind, this document was created to address the needs of the broader sports cardiology community, most of whom work outside specialized cardio-genetics centres, when faced with the evaluation and management of athletes with suspected ICC. The first part of the document provides an overview of basic terminology and principles and offers guidance on the appropriate use of genetic testing in the assessment of such athletes. It outlines key considerations when contemplating genetic testing, highlighting the potential benefits and pitfalls, and offers a roadmap to genetic testing. The second part of the document presents common clinical scenarios in Sports Cardiology practice, outlining the diagnostic, prognostic, and therapeutic implications of genetic testing, including impact on exercise recommendations. The scope of this document does not extend to a comprehensive description of the genetic basis, investigation, or management of ICCs.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sports / Cardiomegaly, Exercise-Induced Type of study: Etiology_studies / Guideline Limits: Humans Language: En Journal: Eur J Prev Cardiol Year: 2022 Document type: Article Affiliation country: Italia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sports / Cardiomegaly, Exercise-Induced Type of study: Etiology_studies / Guideline Limits: Humans Language: En Journal: Eur J Prev Cardiol Year: 2022 Document type: Article Affiliation country: Italia